Scotiabank analyst Nick Altmann maintained a Hold rating on Confluent (CFLT – Research Report) today and set a price target of $27.00. The ...
JMP Securities analyst Patrick Walravens maintained a Buy rating on Confluent (CFLT – Research Report) today and set a price target of $40.00.
Confluent Health proudly announces the rebranding of IncreMedical Therapy Solutions to Confluent Health System Solutions. This evolution reflects the commitment to partnering with health systems ...
In the last three months, 11 analysts have published ratings on Confluent (NASDAQ:CFLT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...
The Connecticut company’s long-lived logo is now getting a new look tailored for the future and the dramatic shift to digital ...
Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...